Carlos Hernandez
Psychiatry · Houston, TXNPI 1902812548
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.7% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,635 and has fallen 67.1% since, to $868 in 2025. Among psychiatry clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 184 payments — averaging $37.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Supernus Pharmaceuticals, Inc.$972
- Takeda Pharmaceuticals U.S.A., Inc.$483
- Otsuka America Pharmaceutical, Inc.$464
- Axsome Therapeutics, Inc.$453
- Sunovion Pharmaceuticals Inc.$433
- plus $3K from 19 others
What the payments were for
- Speaking & faculty fees$5007%
- Food & beverage$6,34893%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 56 | $1,074 |
| Supernus Pharmaceuticals, Inc. | 9 | $972 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $483 |
| Otsuka America Pharmaceutical, Inc. | 18 | $464 |
| Axsome Therapeutics, Inc. | 8 | $453 |
| Sunovion Pharmaceuticals Inc. | 12 | $433 |
| Lundbeck LLC | 18 | $406 |
| Johnson & Johnson | 6 | $330 |
| Ironshore Pharmaceuticals Inc. | 6 | $317 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $260 |
| Corium, LLC | 8 | $249 |
| Teva Pharmaceuticals USA, Inc. | 2 | $229 |
| Biogen | 2 | $180 |
| Vanda Pharmaceuticals Inc. | 3 | $165 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| E.r. Squibb & Sons, L.L.C. | 1 | $102 |
| Shire North American Group Inc | 4 | $97 |
| Novo Nordisk | 1 | $96 |
| Pharming Healthcare, Inc. | 1 | $94 |
| Medtronic | 1 | $90 |
| Neos Therapeutics, LP | 3 | $57 |
| Alkermes, Inc. | 1 | $22 |
| Avanir Pharmaceuticals, Inc. | 1 | $21 |
| Neuronetics, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,850 in reported general payments places this provider in the 90th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $905 |
| Bupropion XlBupropion Hcl | 16 | $774 |
| Escitalopram Oxalate | 29 | $589 |
| Duloxetine Hcl | 19 | $509 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 19 | $508 |
| Aripiprazole | 17 | $489 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $347 |
| Sertraline Hcl | 25 | $285 |
| Trazodone Hcl | 42 | $258 |
| Buspirone Hcl | 14 | $214 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $161 |
| Lithium Carbonate | 12 | $98 |
| Quetiapine Fumarate | 11 | $65 |
| Alprazolam | 20 | $49 |
| Risperidone | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Houston
- Matthew BramsHouston$1.5M
- Frank ChenHouston$941K
- Alice MaoHouston$850K
- Mazhar KhowajaHouston$843K
- Barry GritzHouston$792K
- Aaron PetersonHouston$700K
- Ayesha RashidHouston$641K
- Lawrence GinsbergHouston$502K
- Kathy FlanaganHouston$443K
- Rayan Al JurdiHouston$359K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.